College students who feel 'invincible' unlikely to accept vaccines, MU researcher finds

July 29, 2009

COLUMBIA, Mo. - Vaccines to protect against sexually transmitted diseases, including HIV and herpes, are being developed and may soon be available to college students. However, limited research has been conducted to determine if students will accept the vaccines once they are available. In a new study, a University of Missouri researcher has found that students who feel invulnerable, or invincible, to physical harm are unlikely to get an HIV vaccine. Alternately, students who feel invulnerable to psychological harm are more likely to get the vaccine.

"Previous researchers have used invulnerability measures to predict health-endangering behaviors in students, but this study is unique in that it considers the role of invulnerability in students' health-protective or preventative behaviors," said Russell Ravert, assistant professor in the MU College of Human Environmental Sciences.

In the study, Ravert measured two invulnerability factors: danger and psychological. Students with increased danger invulnerability, those who viewed themselves as physically invincible, were more likely to decline the vaccine. One explanation is that strong feelings of danger invulnerability may be associated with decreased threat, which can diminish protective behaviors, Ravert said.

Students who felt psychological invulnerability, those who didn't care what others thought, were more likely to accept a vaccine. Students' psychological invulnerability may protect against the possible stigma associated with getting vaccinated for HIV, or other sexually transmitted diseases, Ravert said.

"It is important to determine what factors are associated with vaccine acceptance because not all students will be willing to take vaccines," Ravert said. "Efforts to promote vaccines should consider that students who aren't worried about being harmed are less likely to get the vaccine, even when it's warranted by their sexual behavior."

In the study, the strongest predictor of vaccine acceptance was students' perceived susceptibility to contracting HIV, followed by their number of sexual partners. Students' decisions also were influenced by the cost of the vaccine.

In future studies, Ravert will examine college students' invulnerability beliefs as they relate to risk-taking behaviors and other preventative health behaviors, as well as how invulnerability beliefs vary across age groups. The study, "College Student Invulnerability Beliefs and HIV Vaccine Acceptability," was based on Ravert's dissertation data from Indiana University. It was published in the July/August issue of the American Journal of Health Behavior.
-end-


University of Missouri-Columbia

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.